SAN FRANCISCO, Feb. 18, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the fourth quarter and year-ended December 31, 2019, on Thursday, February 27, 2020, after the close of U.S.-based financial markets. Howard Robin, President

LONG BEACH, Calif., Feb. 18, 2020 /PRNewswire/ -- MemorialCare's Long Beach Medical Center and 

DOWNERS GROVE, Ill., Feb. 18, 2020 /PRNewswire/ -- Univar Solutions Inc. (NYSE: UNVR) ("Univar Solutions" or "The Company"), a global chemical and ingredient distributor and provider of value-added services, today announced the extension of its Pharmaceutical Ingredients as a Dedicated Industry Vertical into Europe,

HOLYOKE, Mass., Feb. 18, 2020 /PRNewswire/ -- Affinity Dental Management, Inc. ("Affinity"), a dental services organization that provides comprehensive management and administrative support services for dental practices, has added the powerhouse dental practice, Concerned Dental to its growing platform. Financial terms of the transaction were not disclosed.

NASHVILLE, Tenn., Feb. 18, 2020 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter and year ended December 31, 2019.

NEW YORK, Feb. 18, 2020 /PRNewswire/ -- WW International, Inc. (NASDAQ: WW), a global wellness company and the world's leading commercial weight management program, today announced that Jennifer Dulski will join the WW Board of Directors, effective as of February 27, 2020. Jennifer served in leadership roles at

AUSTIN, Texas, Feb. 18, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Friday, February 21 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2019, in conjunction with the fili

REHOVOT, Israel and BRIDGEWATER, N.J., Feb. 18, 2020 /PRNewswire/ -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) ("Foamix" or the "Company"), a specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, today announced results from an integrated efficacy analysis on the two pivotal Phase 3 clinical tr

LONDON, Feb. 18, 2020 /PRNewswire/ -- ReNeuron Group plc (AIM: RENE), a global leader in the development of cell-based therapeutics, is pleased to announce the publication in a peer reviewed journal of positive clinical data from the PISCES II Phase 2a clinical trial of its CTX stem cell therapy candidate for disability resulting from stroke. The article, titled "Intrace

RADNOR, Pa., Feb. 18, 2020 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced that Michael Stubblefield, President and Chief Executive Officer, will participate in Cowen